Cargando…

Forecasting the progression of Alzheimer's disease using neural networks and a novel preprocessing algorithm

INTRODUCTION: There is a 99.6% failure rate of clinical trials for drugs to treat Alzheimer's disease, likely because Alzheimer's disease (AD) patients cannot be easily identified at early stages. This study investigated machine learning approaches to use clinical data to predict the progr...

Descripción completa

Detalles Bibliográficos
Autor principal:	Albright, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804703/ https://www.ncbi.nlm.nih.gov/pubmed/31650004 http://dx.doi.org/10.1016/j.trci.2019.07.001

Ejemplares similares

Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progression
por: Firth, Nicholas C., et al.
Publicado: (2020)

A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
por: Lutz, Michael W., et al.
Publicado: (2016)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Neural and behavioral substrates of disorientation in mild cognitive impairment and Alzheimer's disease
por: Sousa, Amber, et al.
Publicado: (2015)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
por: Samtani, Mahesh N., et al.
Publicado: (2015)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials
por: Xu, Steven X., et al.
Publicado: (2015)

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
por: Li, Dan, et al.
Publicado: (2019)

TRT Preprocessing-Algorithm, Implementations and Benchmarks
por: Bock, R, et al.
Publicado: (1997)

Analysis of high‐risk pedigrees identifies 11 candidate variants for Alzheimer's disease
por: Teerlink, Craig C., et al.
Publicado: (2021)

Multilingual automation of transcript preprocessing in Alzheimer's disease detection
por: Abiven, Frédéric, et al.
Publicado: (2021)

Convolution neural network–based Alzheimer's disease classification using hybrid enhanced independent component analysis based segmented gray matter of T2 weighted magnetic resonance imaging with clinical valuation
por: Basheera, Shaik, et al.
Publicado: (2019)

Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary report
por: Weiner, Michael W., et al.
Publicado: (2017)

Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease
por: Soudy, Rania, et al.
Publicado: (2016)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Alzheimer's disease Archimedes condition-event simulator: Development and validation
por: Kansal, Anuraag R., et al.
Publicado: (2018)

Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
por: Boada, Mercè, et al.
Publicado: (2019)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease
por: Burfeind, Kevin G., et al.
Publicado: (2017)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
por: Picard, Cynthia, et al.
Publicado: (2021)

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
por: Evans, Stephanie, et al.
Publicado: (2019)

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study
por: Jutten, Roos J., et al.
Publicado: (2017)

Forecasting individual progression trajectories in Alzheimer’s disease
por: Maheux, Etienne, et al.
Publicado: (2023)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
por: Caldwell, Andrew B., et al.
Publicado: (2022)

An amylin analog used as a challenge test for Alzheimer's disease
por: Zhu, Haihao, et al.
Publicado: (2017)

UB-311, a novel UBITh(®) amyloid β peptide vaccine for mild Alzheimer's disease
por: Wang, Chang Yi, et al.
Publicado: (2017)

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
por: Izzo, Nicholas J., et al.
Publicado: (2021)

Using data science to diagnose and characterize heterogeneity of Alzheimer's disease
por: Ang, Ting F.A., et al.
Publicado: (2019)

Integration of genetic algorithm with artificial neural network for stock market forecasting
por: Sharma, Dinesh K., et al.
Publicado: (2021)

Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population
por: Gustavsson, Erik, et al.
Publicado: (2021)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Accelerating drug development for Alzheimer's disease through the use of data standards
por: Neville, Jon, et al.
Publicado: (2017)

Enhanced Preprocessing Approach Using Ensemble Machine Learning Algorithms for Detecting Liver Disease
por: Md, Abdul Quadir, et al.
Publicado: (2023)

Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
por: Fisher, Charles K., et al.
Publicado: (2019)

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
por: Landen, Jaren W., et al.
Publicado: (2017)

Whole genome sequencing–based copy number variations reveal novel pathways and targets in Alzheimer's disease
por: Ming, Chen, et al.
Publicado: (2021)

Brains–Computers–Machines: Neural Engineering in Science Classrooms
por: Chudler, Eric H., et al.
Publicado: (2016)

Estrogen activates Alzheimer's disease genes
por: Ratnakumar, Abhirami, et al.
Publicado: (2019)

Intranasal rifampicin for Alzheimer's disease prevention
por: Umeda, Tomohiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nueqs41tatf4tmr1sntjnp5euc